the heading of the article is below ...interesting

How PharmAust is offering hope to patients with MND and ALS using veterinary drug monepantel

Cheyanne EncisoThe West Australian

Tue, 2 April 2024 5:00AM
Comments

Cheyanne Enciso

The head of PharmAust says the Perth biotech could offer hope to the hundreds of thousands of patients with motor neurone disease and ALS using a re-purposed veterinary drug approved for sheep drench.

The clinical-stage company completed a phase 1 study in December, with the recent findings revealing the drug monepantel — typically used to remove worm infestations in sheep — reduced the progression of the neuro degenerative diseases by 58 per cent.